{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T19:22:55Z","timestamp":1793128975691,"version":"4.5.0"},"reference-count":123,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Youth Project of Guangxi Natural Science Foundation","award":["2023GXNSFBA026004"],"award-info":[{"award-number":["2023GXNSFBA026004"]}]},{"name":"Baigui youth top talent training program"},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170421 and 82360464"],"award-info":[{"award-number":["82170421 and 82360464"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Young leading talents training program of Guangxi Medical University"},{"name":"Outstanding Young Talent Training Program of Guangxi Medical University"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Enzyme Inhibition and Medicinal Chemistry"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/14756366.2026.2677282","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T10:29:08Z","timestamp":1780050548000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Targeting the BMX in cancer: molecular mechanisms and emerging therapeutic strategies"],"prefix":"10.1080","volume":"41","author":[{"given":"Man","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Experimental Research, Guangxi Medical University Cancer Hospital","place":["Nanning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinchi","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Experimental Research, Guangxi Medical University Cancer Hospital","place":["Nanning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Experimental Research, Guangxi Medical University Cancer Hospital","place":["Nanning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Experimental Research, Guangxi Medical University Cancer Hospital","place":["Nanning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Experimental Research, Guangxi Medical University Cancer Hospital","place":["Nanning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Experimental Research, Guangxi Medical University Cancer Hospital","place":["Nanning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dejun","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Experimental Research, Guangxi Medical University Cancer Hospital","place":["Nanning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Yi","sequence":"additional","affiliation":[{"name":"Department of Experimental Research, Guangxi Medical University Cancer Hospital","place":["Nanning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiqi","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Guangxi Clinical Research Center for Colorectal Cancer, Guangxi Medical University Cancer Hospital","place":["Nanning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyu","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Guangxi Clinical Research Center for Colorectal Cancer, Guangxi Medical University Cancer Hospital","place":["Nanning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Experimental Research, Guangxi Medical University Cancer Hospital","place":["Nanning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"issue":"12","key":"e_1_3_3_2_1","first-page":"3683","article-title":"BMX, a novel nonreceptor tyrosine kinase gene of the BTK\/ITK\/TEC\/TXK family located in chromosome Xp22.2","volume":"9","author":"Tamagnone L","year":"1994","unstructured":"Tamagnone L, Lahtinen I, Mustonen T, Virtaneva K, Francis F, Muscatelli F, Alitalo R, Smith CI, Larsson C, Alitalo K, et al. BMX, a novel nonreceptor tyrosine kinase gene of the BTK\/ITK\/TEC\/TXK family located in chromosome Xp22.2. Oncogene. 1994;9(12):3683\u20133688.","journal-title":"Oncogene"},{"issue":"1","key":"e_1_3_3_3_1","first-page":"6","article-title":"The Tec family protein-tyrosine kinases: a subset of kinases for a subset of signalings","volume":"69","author":"Mano H.","year":"1999","unstructured":"Mano H. The Tec family protein-tyrosine kinases: a subset of kinases for a subset of signalings. Int J Hematol. 1999;69(1):6\u201312.","journal-title":"Int J Hematol"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.7.3644"},{"key":"e_1_3_3_5_1","doi-asserted-by":"crossref","first-page":"1726458","DOI":"10.3389\/fphar.2025.1726458","article-title":"Advancements in research on the cardiovascular toxicity caused by TEC family kinases inhibitors","volume":"16","author":"Zhang Y","year":"2025","unstructured":"Zhang Y, Fu H, Kang X, Qiu Z, Yan H, He Q, Yang B, Xu Z, Luo P. Advancements in research on the cardiovascular toxicity caused by TEC family kinases inhibitors. Front Pharmacol. 2025;16:1726458.","journal-title":"Front Pharmacol"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/pro.2887"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1570-9639(02)00524-1"},{"issue":"277","key":"e_1_3_3_8_1","doi-asserted-by":"crossref","first-page":"ra40","DOI":"10.1126\/scisignal.2003936","article-title":"Tyrosine kinase BMX phosphorylates phosphotyrosine-primed motif mediating the activation of multiple receptor tyrosine kinases","volume":"6","author":"Chen S","year":"2013","unstructured":"Chen S, Jiang X, Gewinner CA, Asara JM, Simon NI, Cai C, Cantley LC, Balk SP. Tyrosine kinase BMX phosphorylates phosphotyrosine-primed motif mediating the activation of multiple receptor tyrosine kinases. Sci Signal. 2013;6(277):ra40.","journal-title":"Sci Signal"},{"issue":"120","key":"e_1_3_3_9_1","doi-asserted-by":"crossref","first-page":"ra34","DOI":"10.1126\/scisignal.2000796","article-title":"Loops govern SH2 domain specificity by controlling access to binding pockets","volume":"3","author":"Kaneko T","year":"2010","unstructured":"Kaneko T, Huang H, Zhao B, Li L, Liu H, Voss CK, Wu C, Schiller MR, Li SS-C. Loops govern SH2 domain specificity by controlling access to binding pockets. Sci Signal. 2010;3(120):ra34.","journal-title":"Sci Signal"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1039\/D0CB00033G"},{"issue":"8","key":"e_1_3_3_11_1","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s00403-024-03229-0","article-title":"A review of TEC family kinases and their inhibitors in the treatment of alopecia areata","volume":"316","author":"An Y","year":"2024","unstructured":"An Y, Zhang F. A review of TEC family kinases and their inhibitors in the treatment of alopecia areata. Arch Dermatol Res. 2024;316(8):496.","journal-title":"Arch Dermatol Res"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1359-6101(99)00019-2"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/bies.1062"},{"issue":"1","key":"e_1_3_3_14_1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41420-022-00927-4","article-title":"Regulation of the Tec family of non-receptor tyrosine kinases in cardiovascular disease","volume":"8","author":"Yin Z","year":"2022","unstructured":"Yin Z, Zou Y, Wang D, Huang X, Xiong S, Cao L, Zhang Y, Sun Y, Zhang N. Regulation of the Tec family of non-receptor tyrosine kinases in cardiovascular disease. Cell Death Discov. 2022;8(1):119.","journal-title":"Cell Death Discov"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1203958"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M108537200"},{"issue":"21","key":"e_1_3_3_17_1","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1038\/sj.onc.1201799","article-title":"Tec is involved in G protein-coupled receptor- and integrin-mediated signalings in human blood platelets","volume":"16","author":"Hamazaki Y","year":"1998","unstructured":"Hamazaki Y, Kojima H, Mano H, Nagata Y, Todokoro K, Abe T, Nagasawa T. Tec is involved in G protein-coupled receptor- and integrin-mediated signalings in human blood platelets. Oncogene. 1998;16(21):2773\u20132779.","journal-title":"Oncogene"},{"key":"e_1_3_3_18_1","doi-asserted-by":"crossref","first-page":"OF29","DOI":"10.1158\/2159-8290.CD-RW2013-122","article-title":"BMX promotes dual phosphorylation of tyrosine kinases","volume":"3","year":"2013","unstructured":"BMX promotes dual phosphorylation of tyrosine kinases. Cancer Discov. 2013;3:OF29.","journal-title":"Cancer Discov"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.20.6.2043-2054.2000"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1203763"},{"issue":"11","key":"e_1_3_3_21_1","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41577-022-00701-8","article-title":"The role of PI3K\u03b3 in the immune system: new insights and translational implications","volume":"22","author":"Lanahan SM","year":"2022","unstructured":"Lanahan SM, Wymann MP, Lucas CL. The role of PI3K\u03b3 in the immune system: new insights and translational implications. Nat Rev Immunol. 2022;22(11):687\u2013700.","journal-title":"Nat Rev Immunol"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-11-0218"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aah6816"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2017.04.025"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00791-1"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.5.3485"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-07-102343"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.3109\/08830185.2012.670334"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.108.186577"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1517810112"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.110.214999"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-1364"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12282-019-01024-8"},{"issue":"1","key":"e_1_3_3_34_1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1756-9966-33-25","article-title":"The expression and role of tyrosine kinase ETK\/BMX in renal cell carcinoma","volume":"33","author":"Zhuang J","year":"2014","unstructured":"Zhuang J, Tu X, Cao K, Guo S, Mao X, Pan J, Huang B, Chen X, Gao Y, Qiu S, et al. The expression and role of tyrosine kinase ETK\/BMX in renal cell carcinoma. J Exp Clin Cancer Res. 2014;33(1):25.","journal-title":"J Exp Clin Cancer Res"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.156094"},{"key":"e_1_3_3_36_1","doi-asserted-by":"crossref","first-page":"1581398","DOI":"10.3389\/fimmu.2025.1581398","article-title":"PSMD12 promotes hepatocellular carcinoma progression by stabilizing CDK1","volume":"16","author":"Peng X","year":"2025","unstructured":"Peng X, Liu Z, Luo C, Sun R, Zhang Y, Li B, Zou Y, Zhu J, Yuan R. PSMD12 promotes hepatocellular carcinoma progression by stabilizing CDK1. Front Immunol. 2025;16:1581398.","journal-title":"Front Immunol"},{"issue":"0","key":"e_1_3_3_37_1","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.36922\/arnm.1667","article-title":"Fibroblast activation protein-targeted radioligand therapy in various types of cancer: background, clinical studies, and future development","volume":"0","author":"Pang Y","year":"2023","unstructured":"Pang Y, Zhao L, Chen J, Xu W, Cai J, Chen H, Lin Q. Fibroblast activation protein-targeted radioligand therapy in various types of cancer: background, clinical studies, and future development. ARNM. 2023;0(0):1667.","journal-title":"ARNM"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2025.118209"},{"key":"e_1_3_3_39_1","doi-asserted-by":"crossref","first-page":"108198","DOI":"10.1016\/j.compbiomed.2024.108198","article-title":"Identification of cuproptosis-related lncRNAs with the significance in prognosis and immunotherapy of oral squamous cell carcinoma","volume":"171","author":"Gong H","year":"2024","unstructured":"Gong H, Liu Z, Yuan C, Luo Y, Chen Y, Zhang J, Cui Y, Zeng B, Liu J, Li H, et al. Identification of cuproptosis-related lncRNAs with the significance in prognosis and immunotherapy of oral squamous cell carcinoma. Comput Biol Med. 2024;171:108198.","journal-title":"Comput Biol Med"},{"issue":"6","key":"e_1_3_3_40_1","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1109\/TCBB.2020.2973148","article-title":"FUNMarker: fusion network-based method to identify prognostic and heterogeneous breast cancer biomarkers","volume":"18","author":"Li X","year":"2021","unstructured":"Li X, Xiang J, Wang J, Li J, Wu F-X, Li M. FUNMarker: fusion network-based method to identify prognostic and heterogeneous breast cancer biomarkers. IEEE\/ACM Trans Comput Biol Bioinform. 2021;18(6):2483\u20132491.","journal-title":"IEEE\/ACM Trans Comput Biol Bioinform"},{"key":"e_1_3_3_41_1","first-page":"0948","article-title":"Chronic psychological stress in oncogenesis: multisystem crosstalk and multimodal interventions","volume":"8","author":"Huang B","year":"2025","unstructured":"Huang B, An H, Wu H, Qiu Y, Su Y, Chen L, Georgakopoulou VE, Lin J, Chen W, Li R, et al. Chronic psychological stress in oncogenesis: multisystem crosstalk and multimodal interventions. Research (Wash D C). 2025;8:0948.","journal-title":"Research (Wash D C)"},{"issue":"1","key":"e_1_3_3_42_1","doi-asserted-by":"crossref","first-page":"e70377","DOI":"10.1002\/pon.70377","article-title":"The effectiveness of telemedicine-based psychosocial intervention for fear of cancer recurrence, mindfulness, and posttraumatic growth in cancer survivors: a systematic review and meta-analysis of randomized controlled trials","volume":"35","author":"Su Y","year":"2026","unstructured":"Su Y, Zhang S, Duan L, Hu X. The effectiveness of telemedicine-based psychosocial intervention for fear of cancer recurrence, mindfulness, and posttraumatic growth in cancer survivors: a systematic review and meta-analysis of randomized controlled trials. Psychooncology. 2026;35(1):e70377.","journal-title":"Psychooncology"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101751"},{"key":"e_1_3_3_44_1","doi-asserted-by":"crossref","first-page":"1689103","DOI":"10.3389\/fimmu.2025.1689103","article-title":"Identification and validation of prognostic genes and prognostic models associated with cutaneous melanoma and integrative stress response","volume":"16","author":"Zhang Z","year":"2025","unstructured":"Zhang Z, Wang Y, Yin W, Lei Q, Fu Y, Liang Y, Li R, Li K. Identification and validation of prognostic genes and prognostic models associated with cutaneous melanoma and integrative stress response. Front Immunol. 2025;16:1689103.","journal-title":"Front Immunol"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2025.08.003"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S466042"},{"issue":"5","key":"e_1_3_3_47_1","doi-asserted-by":"crossref","first-page":"051701","DOI":"10.3788\/COL202018.051701","article-title":"Detection of breast cancer based on novel porous silicon Bragg reflector surface-enhanced Raman spectroscopy-active structure","volume":"18","author":"Ma X","year":"2020","unstructured":"Ma X, Cheng H, Hou J, Jia Z, Wu G, L\u00fc X, Li H, Zheng X, Chen C. Detection of breast cancer based on novel porous silicon Bragg reflector surface-enhanced Raman spectroscopy-active structure. Chin Opt Lett. 2020;18(5):051701.","journal-title":"Chin Opt Lett"},{"key":"e_1_3_3_48_1","doi-asserted-by":"crossref","first-page":"901559","DOI":"10.3389\/fphar.2022.901559","article-title":"Effects of GLP-1 receptor agonists on biological behavior of colorectal cancer cells by regulating PI3K\/AKT\/mTOR signaling pathway","volume":"13","author":"Tong G","year":"2022","unstructured":"Tong G, Peng T, Chen Y, Sha L, Dai H, Xiang Y, Zou Z, He H, Wang S. Effects of GLP-1 receptor agonists on biological behavior of colorectal cancer cells by regulating PI3K\/AKT\/mTOR signaling pathway. Front Pharmacol. 2022;13:901559.","journal-title":"Front Pharmacol"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-1340"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.343"},{"issue":"5","key":"e_1_3_3_51_1","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1159\/000113491","article-title":"Expression of tyrosine kinase Etk\/Bmx and its relationship with AP-1- and NF-kappaB-associated proteins in hepatocellular carcinoma","volume":"72","author":"Guo L","year":"2007","unstructured":"Guo L, Guo Y, Xiao S. Expression of tyrosine kinase Etk\/Bmx and its relationship with AP-1- and NF-kappaB-associated proteins in hepatocellular carcinoma. Oncology. 2007;72(5-6):410\u2013416.","journal-title":"Oncology"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1002\/jso.20983"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.17493"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017778"},{"issue":"14","key":"e_1_3_3_55_1","doi-asserted-by":"crossref","first-page":"e169647","DOI":"10.1172\/jci.insight.169647","article-title":"Preclinical spheroid models identify BMX as a therapeutic target for metastatic MYCN nonamplified neuroblastoma","volume":"9","author":"Sundaramoorthy S","year":"2024","unstructured":"Sundaramoorthy S, Colombo DF, Sanalkumar R, Broye L, Balmas Bourloud K, Boulay G, Cironi L, Stamenkovic I, Renella R, Kuttler F, et al. Preclinical spheroid models identify BMX as a therapeutic target for metastatic MYCN nonamplified neuroblastoma. JCI Insight. 2024;9(14):e169647.","journal-title":"JCI Insight"},{"issue":"1","key":"e_1_3_3_56_1","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1172\/JCI91893","article-title":"Hypoxia-induced upregulation of BMX kinase mediates therapeutic resistance in acute myeloid leukemia","volume":"128","author":"van Oosterwijk JG","year":"2018","unstructured":"van Oosterwijk JG, Buelow DR, Drenberg CD, Vasilyeva A, Li L, Shi L, Wang Y-D, Finkelstein D, Shurtleff SA, Janke LJ, et al. Hypoxia-induced upregulation of BMX kinase mediates therapeutic resistance in acute myeloid leukemia. J Clin Invest. 2018;128(1):369\u2013380.","journal-title":"J Clin Invest"},{"issue":"2","key":"e_1_3_3_57_1","doi-asserted-by":"crossref","first-page":"e163498","DOI":"10.1172\/JCI163498","article-title":"BMX controls 3\u03b2HSD1 and sex steroid biosynthesis in cancer","volume":"133","author":"Li X","year":"2023","unstructured":"Li X, Berk M, Goins C, Alyamani M, Chung Y-M, Wang C, Patel M, Rathi N, Zhu Z, Willard B, et al. BMX controls 3\u03b2HSD1 and sex steroid biosynthesis in cancer. J Clin Invest. 2023;133(2):e163498.","journal-title":"J Clin Invest"},{"issue":"2","key":"e_1_3_3_58_1","doi-asserted-by":"crossref","first-page":"e166499","DOI":"10.1172\/JCI166499","article-title":"A phosphorylation switch controls androgen biosynthesis in prostate cancer","volume":"133","author":"Qiu Y.","year":"2023","unstructured":"Qiu Y. A phosphorylation switch controls androgen biosynthesis in prostate cancer. J Clin Invest. 2023;133(2):e166499.","journal-title":"J Clin Invest"},{"issue":"1","key":"e_1_3_3_59_1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1186\/s12967-024-05273-w","article-title":"TRIM26 inhibits clear cell renal cell carcinoma progression through destabilizing ETK and thus inactivation of AKT\/mTOR signaling","volume":"22","author":"Zheng D","year":"2024","unstructured":"Zheng D, Ning J, Deng H, Ruan Y, Cheng F. TRIM26 inhibits clear cell renal cell carcinoma progression through destabilizing ETK and thus inactivation of AKT\/mTOR signaling. J Transl Med. 2024;22(1):481.","journal-title":"J Transl Med"},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-20-3558"},{"issue":"18","key":"e_1_3_3_61_1","doi-asserted-by":"crossref","first-page":"e2412520","DOI":"10.1002\/advs.202412520","article-title":"The super enhancer-driven long noncoding RNA PRKCQ-AS1 promotes neuroblastoma tumorigenesis by interacting with MSI2 protein and is targetable by small molecule compounds","volume":"12","author":"Mondal S","year":"2025","unstructured":"Mondal S, Liu PY, Seneviratne J, De Weck A, Venkat P, Mayoh C, Wu J, Maag J, Chen J, Wong M, et al. The super enhancer-driven long noncoding RNA PRKCQ-AS1 promotes neuroblastoma tumorigenesis by interacting with MSI2 protein and is targetable by small molecule compounds. Adv Sci (Weinh). 2025;12(18):e2412520.","journal-title":"Adv Sci (Weinh)"},{"issue":"3","key":"e_1_3_3_62_1","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.yexmp.2010.02.003","article-title":"Non-receptor tyrosine kinase Etk is involved in the apoptosis of small cell lung cancer cells","volume":"88","author":"Guo L","year":"2010","unstructured":"Guo L, Chen P, Zhou Y, Sun Y. Non-receptor tyrosine kinase Etk is involved in the apoptosis of small cell lung cancer cells. Exp Mol Pathol. 2010;88(3):401\u2013406.","journal-title":"Exp Mol Pathol"},{"issue":"10","key":"e_1_3_3_63_1","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1515\/BC.2011.087","article-title":"Ligand-independent activation of the arylhydrocarbon receptor by ETK (Bmx) tyrosine kinase helps MCF10AT1 breast cancer cells to survive in an apoptosis-inducing environment","volume":"392","author":"Fujisawa Y","year":"2011","unstructured":"Fujisawa Y, Li W, Wu D, Wong P, Vogel C, Dong B, Kung H-J, Matsumura F. Ligand-independent activation of the arylhydrocarbon receptor by ETK (Bmx) tyrosine kinase helps MCF10AT1 breast cancer cells to survive in an apoptosis-inducing environment. Biol Chem. 2011;392(10):897\u2013908.","journal-title":"Biol Chem"},{"key":"e_1_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M409108200"},{"key":"e_1_3_3_65_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1202687"},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.11.7.15060"},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2018.12.001"},{"key":"e_1_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.16796"},{"issue":"3","key":"e_1_3_3_69_1","first-page":"628","article-title":"miR-495 promotes the chemoresistance of SCLC through the epithelial-mesenchymal transition via Etk\/BMX","volume":"7","author":"Wei T","year":"2017","unstructured":"Wei T, Zhu W, Fang S, Zeng X, Huang J, Yang J, Zhang J, Guo L. miR-495 promotes the chemoresistance of SCLC through the epithelial-mesenchymal transition via Etk\/BMX. Am J Cancer Res. 2017;7(3):628\u2013646.","journal-title":"Am J Cancer Res"},{"key":"e_1_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0011135"},{"key":"e_1_3_3_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2021.09.024"},{"issue":"1","key":"e_1_3_3_72_1","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s13000-014-0218-4","article-title":"Identification of a novel gene fusion (BMX-ARHGAP) in gastric cardia adenocarcinoma","volume":"9","author":"Xu X","year":"2014","unstructured":"Xu X, Xu L, Gao F, Wang J, Ye J, Zhou M, Zhu Y, Tao L. Identification of a novel gene fusion (BMX-ARHGAP) in gastric cardia adenocarcinoma. Diagn Pathol. 2014;9(1):218.","journal-title":"Diagn Pathol"},{"issue":"1","key":"e_1_3_3_73_1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12935-019-0847-5","article-title":"BMX-ARHGAP fusion protein maintains the tumorigenicity of gastric cancer stem cells by activating the JAK\/STAT3 signaling pathway","volume":"19","author":"Xu X-F","year":"2019","unstructured":"Xu X-F, Gao F, Wang J-J, Long C, Chen X, Tao L, Yang L, Ding L, Ji Y. BMX-ARHGAP fusion protein maintains the tumorigenicity of gastric cancer stem cells by activating the JAK\/STAT3 signaling pathway. Cancer Cell Int. 2019;19(1):133.","journal-title":"Cancer Cell Int"},{"key":"e_1_3_3_74_1","doi-asserted-by":"publisher","DOI":"10.1080\/1354750X.2022.2157875"},{"key":"e_1_3_3_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2011.03.004"},{"key":"e_1_3_3_76_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-025-01494-8"},{"key":"e_1_3_3_77_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0081592"},{"key":"e_1_3_3_78_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01460-1"},{"key":"e_1_3_3_79_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.14663"},{"key":"e_1_3_3_80_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-1070"},{"key":"e_1_3_3_81_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M310678200"},{"key":"e_1_3_3_82_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.22.21.7512-7523.2002"},{"issue":"9","key":"e_1_3_3_83_1","first-page":"2344","article-title":"Critical function of Bmx\/Etk in ischemia-mediated arteriogenesis and angiogenesis","volume":"116","author":"He Y","year":"2006","unstructured":"He Y, Luo Y, Tang S, Rajantie I, Salven P, Heil M, Zhang R, Luo D, Li X, Chi H, et al. Critical function of Bmx\/Etk in ischemia-mediated arteriogenesis and angiogenesis. J Clin Invest. 2006;116(9):2344\u20132355.","journal-title":"J Clin Invest"},{"key":"e_1_3_3_84_1","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.e04-03-0241"},{"key":"e_1_3_3_85_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1730-1"},{"issue":"3","key":"e_1_3_3_86_1","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.ejca.2009.11.009","article-title":"Non-receptor tyrosine kinase Etk regulation of drug resistance in small-cell lung cancer","volume":"46","author":"Guo L","year":"2010","unstructured":"Guo L, Zhou Y, Sun Y, Zhang F. Non-receptor tyrosine kinase Etk regulation of drug resistance in small-cell lung cancer. Eur J Cancer. 2010;46(3):636\u2013641.","journal-title":"Eur J Cancer"},{"key":"e_1_3_3_87_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-019-0984-2"},{"key":"e_1_3_3_88_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-1475"},{"key":"e_1_3_3_89_1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41392-026-02644-1","article-title":"BMX inhibition overcomes small cell lung cancer chemoresistance by stabilizing E2F1 via ERK1\/2-Cyclin D1\/CDK4\/6 axis","volume":"11","author":"Wu T","year":"2026","unstructured":"Wu T, et al. BMX inhibition overcomes small cell lung cancer chemoresistance by stabilizing E2F1 via ERK1\/2-Cyclin D1\/CDK4\/6 axis. Signal Transduct Target Ther. 2026;11:125.","journal-title":"Signal Transduct Target Ther"},{"key":"e_1_3_3_90_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-4610"},{"key":"e_1_3_3_91_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M116.737387"},{"issue":"17","key":"e_1_3_3_92_1","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.1182\/bloodadvances.2022007952","article-title":"BMX kinase mediates gilteritinib resistance in FLT3-mutated AML through microenvironmental factors","volume":"6","author":"Buelow DR","year":"2022","unstructured":"Buelow DR, Bhatnagar B, Orwick SJ, Jeon JY, Eisenmann ED, Stromatt JC, Pabla NS, Blachly JS, Baker SD, Blaser BW, et al. BMX kinase mediates gilteritinib resistance in FLT3-mutated AML through microenvironmental factors. Blood Adv. 2022;6(17):5049\u20135060.","journal-title":"Blood Adv"},{"issue":"1","key":"e_1_3_3_93_1","doi-asserted-by":"crossref","first-page":"150362","DOI":"10.1016\/j.ijbiomac.2026.150362","article-title":"Bone marrow tyrosine kinase on chromosome X promotes epithelial-mesenchymal transition through signal transducer and activator of transcription 3 in colorectal cancer","volume":"344","author":"Zhang M","year":"2026","unstructured":"Zhang M, Lin M, Wen S, Liu D, Chen T, Chen R, Chen J, Yi B, Liang R, Jiang W, et al. Bone marrow tyrosine kinase on chromosome X promotes epithelial-mesenchymal transition through signal transducer and activator of transcription 3 in colorectal cancer. Int J Biol Macromol. 2026;344(Pt 1):150362.","journal-title":"Int J Biol Macromol"},{"issue":"8","key":"e_1_3_3_94_1","first-page":"e68093","article-title":"Bioinformatic analysis reveals bone marrow kinase as a potential diagnostic and prognostic biomarker for multiple cancer types","volume":"16","author":"Khalafallah SA","year":"2024","unstructured":"Khalafallah SA, Eltayeb Ahmed EA, Elnour LS, Mohammed R, Makawi A, Mohamed AK, Balla A, Alamin MF, Alfaki M. Bioinformatic analysis reveals bone marrow kinase as a potential diagnostic and prognostic biomarker for multiple cancer types. Cureus. 2024;16(8):e68093.","journal-title":"Cureus"},{"key":"e_1_3_3_95_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkac394"},{"issue":"7","key":"e_1_3_3_96_1","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1021\/cb4000629","article-title":"Discovery of a selective irreversible BMX inhibitor for prostate cancer","volume":"8","author":"Liu F","year":"2013","unstructured":"Liu F, Zhang X, Weisberg E, Chen S, Hur W, Wu H, Zhao Z, Wang W, Mao M, Cai C, et al. Discovery of a selective irreversible BMX inhibitor for prostate cancer. ACS Chem Biol. 2013;8(7):1423\u20131428.","journal-title":"ACS Chem Biol"},{"key":"e_1_3_3_97_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-3615"},{"issue":"1","key":"e_1_3_3_98_1","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/s41419-025-08131-9","article-title":"Inhibition of tyrosine kinase BMX increases cell death in response to existing chemotherapeutic agents overcoming apoptotic resistance in cancer","volume":"16","author":"Morad D","year":"2025","unstructured":"Morad D, Skinner S, Bowman K, Seewooruthun C, Fox JL. Inhibition of tyrosine kinase BMX increases cell death in response to existing chemotherapeutic agents overcoming apoptotic resistance in cancer. Cell Death Dis. 2025;16(1):813.","journal-title":"Cell Death Dis"},{"key":"e_1_3_3_99_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.4c01947"},{"key":"e_1_3_3_100_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2017.07.009"},{"key":"e_1_3_3_101_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.6b01413"},{"key":"e_1_3_3_102_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2021.109747"},{"issue":"8","key":"e_1_3_3_103_1","doi-asserted-by":"crossref","first-page":"e70910","DOI":"10.1371\/journal.pone.0070910","article-title":"CTA095, a novel Etk and Src dual inhibitor, induces apoptosis in prostate cancer cells and overcomes resistance to Src inhibitors","volume":"8","author":"Guo W","year":"2013","unstructured":"Guo W, Liu R, Bhardwaj G, Ma A-H, Changou C, Yang JC, Li Y, Feng C, Luo Y, Mazloom A, et al. CTA095, a novel Etk and Src dual inhibitor, induces apoptosis in prostate cancer cells and overcomes resistance to Src inhibitors. PLoS One. 2013;8(8):e70910.","journal-title":"PLoS One"},{"key":"e_1_3_3_104_1","doi-asserted-by":"publisher","DOI":"10.1186\/1756-8722-6-59"},{"key":"e_1_3_3_105_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12195-022-00723-1"},{"key":"e_1_3_3_106_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-017-0549-6"},{"issue":"1","key":"e_1_3_3_107_1","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s40478-024-01763-6","article-title":"Ibrutinib disrupts blood-tumor barrier integrity and prolongs survival in rodent glioma model","volume":"12","author":"Lim S","year":"2024","unstructured":"Lim S, Kwak M, Kang J, Cesaire M, Tang K, Robey RW, Frye WJE, Karim B, Butcher D, Lizak MJ, et al. Ibrutinib disrupts blood-tumor barrier integrity and prolongs survival in rodent glioma model. Acta Neuropathol Commun. 2024;12(1):56.","journal-title":"Acta Neuropathol Commun"},{"issue":"844","key":"e_1_3_3_108_1","doi-asserted-by":"crossref","first-page":"eaed1155","DOI":"10.1126\/scitranslmed.aed1155","article-title":"Pharmacological activation of WASp potentiates macrophage phagocytosis and enhances ibrutinib efficacy against mouse models of brain tumors","volume":"18","author":"Cheng Y","year":"2026","unstructured":"Cheng Y, Li T, Wang M, Lan C, Fan H, He Z, Liu Q, Li F, Wang L, Wang W, et al. Pharmacological activation of WASp potentiates macrophage phagocytosis and enhances ibrutinib efficacy against mouse models of brain tumors. Sci Transl Med. 2026;18(844):eaed1155.","journal-title":"Sci Transl Med"},{"key":"e_1_3_3_109_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16407"},{"key":"e_1_3_3_110_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12051328"},{"key":"e_1_3_3_111_1","doi-asserted-by":"crossref","first-page":"737943","DOI":"10.3389\/fonc.2021.737943","article-title":"Clinical trials of the BTK inhibitors ibrutinib and acalabrutinib in human diseases beyond B cell malignancies","volume":"11","author":"Zhu S","year":"2021","unstructured":"Zhu S, Jung J, Victor E, Arceo J, Gokhale S, Xie P. Clinical trials of the BTK inhibitors ibrutinib and acalabrutinib in human diseases beyond B cell malignancies. Front Oncol. 2021;11:737943.","journal-title":"Front Oncol"},{"key":"e_1_3_3_112_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.9b00687"},{"issue":"1","key":"e_1_3_3_113_1","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41408-023-00902-x","article-title":"Zanubrutinib: past, present, and future","volume":"13","author":"Tam CS","year":"2023","unstructured":"Tam CS, Mu\u00f1oz JL, Seymour JF, Opat S. Zanubrutinib: past, present, and future. Blood Cancer J. 2023;13(1):141.","journal-title":"Blood Cancer J"},{"key":"e_1_3_3_114_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2211582"},{"issue":"1","key":"e_1_3_3_115_1","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s13045-022-01353-w","article-title":"BTK inhibitors in the treatment of hematological malignancies and inflammatory diseases: mechanisms and clinical studies","volume":"15","author":"Alu A","year":"2022","unstructured":"Alu A, Lei H, Han X, Wei Y, Wei X. BTK inhibitors in the treatment of hematological malignancies and inflammatory diseases: mechanisms and clinical studies. J Hematol Oncol. 2022;15(1):138.","journal-title":"J Hematol Oncol"},{"key":"e_1_3_3_116_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.200893"},{"issue":"1","key":"e_1_3_3_117_1","doi-asserted-by":"crossref","first-page":"18671","DOI":"10.1038\/s41598-021-98255-7","article-title":"Target modulation and pharmacokinetics\/pharmacodynamics translation of the BTK inhibitor poseltinib for model-informed phase II dose selection","volume":"11","author":"Byun J-Y","year":"2021","unstructured":"Byun J-Y, Koh YT, Jang SY, Witcher JW, Chan JR, Pustilnik A, Daniels MJ, Kim YH, Suh KH, Linnik MD, et al. Target modulation and pharmacokinetics\/pharmacodynamics translation of the BTK inhibitor poseltinib for model-informed phase II dose selection. Sci Rep. 2021;11(1):18671.","journal-title":"Sci Rep"},{"issue":"14","key":"e_1_3_3_118_1","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s40265-023-01928-y","article-title":"Ritlecitinib: first approval","volume":"83","author":"Blair HA.","year":"2023","unstructured":"Blair HA. Ritlecitinib: first approval. Drugs. 2023;83(14):1315\u20131321.","journal-title":"Drugs"},{"issue":"4","key":"e_1_3_3_119_1","doi-asserted-by":"crossref","first-page":"e1204","DOI":"10.1002\/prp2.1204","article-title":"A phase 2a study investigating the effects of ritlecitinib on brainstem auditory evoked potentials and intraepidermal nerve fiber histology in adults with alopecia areata","volume":"12","author":"Anderson S","year":"2024","unstructured":"Anderson S, Cavaletti G, Hood LJ, Polydefkis M, Herrmann DN, Rance G, King B, McMichael AJ, Senna MM, Kim BS, et al. A phase 2a study investigating the effects of ritlecitinib on brainstem auditory evoked potentials and intraepidermal nerve fiber histology in adults with alopecia areata. Pharmacol Res Perspect. 2024;12(4):e1204.","journal-title":"Pharmacol Res Perspect"},{"key":"e_1_3_3_120_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.41316"},{"key":"e_1_3_3_121_1","first-page":"7628734","article-title":"The effect of canertinib on sensitivity of cytotoxic drugs in tamoxifen-resistant breast cancer cells in vitro","volume":"2018","author":"Gomaa HAM","year":"2018","unstructured":"Gomaa HAM, Ali AT, Gabbar MA, Kandeil MA. The effect of canertinib on sensitivity of cytotoxic drugs in tamoxifen-resistant breast cancer cells in vitro. Int J Genomics. 2018;2018:7628734\u20137628710.).","journal-title":"Int J Genomics"},{"issue":"1","key":"e_1_3_3_122_1","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1039\/C6MD00463F","article-title":"Tumor cell resistance against targeted therapeutics: the density of cultured glioma tumor cells enhances Stat3 activity and offers protection against the tyrosine kinase inhibitor canertinib","volume":"8","author":"von Manstein V","year":"2017","unstructured":"von Manstein V, Groner B. Tumor cell resistance against targeted therapeutics: the density of cultured glioma tumor cells enhances Stat3 activity and offers protection against the tyrosine kinase inhibitor canertinib. Medchemcomm. 2017;8(1):96\u2013102.","journal-title":"Medchemcomm"},{"key":"e_1_3_3_123_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.heares.2015.07.002"},{"key":"e_1_3_3_124_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.123384"}],"container-title":["Journal of Enzyme Inhibition and Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14756366.2026.2677282","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T10:29:15Z","timestamp":1780050555000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14756366.2026.2677282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":123,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/14756366.2026.2677282"],"URL":"https:\/\/doi.org\/10.1080\/14756366.2026.2677282","relation":{},"ISSN":["1475-6366","1475-6374"],"issn-type":[{"value":"1475-6366","type":"print"},{"value":"1475-6374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ienz20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ienz20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-03-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-19","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2677282"}}